The Biden administration spent $267 million on research grants and contracts related to "misinformation" in 2021, a watchdog ...

Under normal circumstances, the study of health problems after COVID vaccinations posted online on Feb. 25 might not have ...

As the world marks the fifth anniversary of the start of the coronavirus pandemic, one question has persisted: How many lives ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

Academically, socially, and institutionally, America has not yet recovered from COVID-19 on the fifth anniversary of ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Five years after the WHO declared the COVID global outbreak to be a pandemic, frontline health care workers reflect on what they remember of the early days of COVID.

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

A small U.S. study explored whether immune markers seen in many long COVID sufferers are also present in people with ...

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...